BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38364619)

  • 1. Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME).
    Rajska A; Raczak-Gutknecht J; Struck-Lewicka W; Buszewska-Forajta M; Wityk P; Verding P; Kowalewska A; Siluk D; Rachoń D; Jan Markuszewski M
    J Chromatogr A; 2024 Mar; 1718():464735. PubMed ID: 38364619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS/MS.
    Cao Z; Lu Y; Cong Y; Liu Y; Li Y; Wang H; Zhang Q; Huang W; Liu J; Dong Y; Tang G; Luo YR; Yin C; Zhai Y
    J Clin Lab Anal; 2020 Dec; 34(12):e23539. PubMed ID: 32820576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
    Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
    Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
    Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
    PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of 5α-androstanedione in normal women and women with PCOS.
    Stanczyk FZ; Mandelbaum R; Baker M; Ma L; Sriprasert I; Dancz CE; Legro RS
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106289. PubMed ID: 36972792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome.
    Ge J; Yang N; Zhang X; Li M; Zhang W; He J; Zhu H; Cheng X; Shen S; Ge W
    Reprod Sci; 2022 Dec; 29(12):3449-3458. PubMed ID: 35835901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
    Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a thin-film solid-phase microextraction (TF-SPME) method coupled to liquid chromatography and tandem mass spectrometry for high-throughput determination of steroid hormones in white sucker fish plasma.
    Maciążek-Jurczyk M; Bessonneau V; Ings J; Bragg L; McMaster M; Servos MR; Bojko B; Pawliszyn J
    Anal Bioanal Chem; 2020 Jul; 412(17):4183-4194. PubMed ID: 32361868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
    Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of total testosterone and free androgen index measured by LC-MS/MS for PCOS and insulin resistance.
    Xu S; Liu Y; Xue K; Liu X; Jia G; Zeng Y; Chen Y
    J Clin Lab Anal; 2022 Nov; 36(11):e24739. PubMed ID: 36258308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders.
    Wang Z; Wang H; Peng Y; Chen F; Zhao L; Li X; Qin J; Li Q; Wang B; Pan B; Guo W
    Clin Chem Lab Med; 2020 Aug; 58(9):1477-1487. PubMed ID: 32084000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of Classical and 11-Oxygenated Androgens by Insulin-Induced AKR1C3 in a Model of Human PCOS Adipocytes.
    Paulukinas RD; Mesaros CA; Penning TM
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35560164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
    Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
    Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Serum Levels of 11-Oxygenated Metabolites of Testosterone in Women With Polycystic Ovary Syndrome.
    Tosi F; Villani M; Garofalo S; Faccin G; Bonora E; Fiers T; Kaufman JM; Moghetti P
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2047-e2055. PubMed ID: 34951635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidogenic pathways involved in androgen biosynthesis in eumenorrheic women and patients with polycystic ovary syndrome.
    Saito K; Matsuzaki T; Iwasa T; Miyado M; Saito H; Hasegawa T; Homma K; Inoue E; Miyashiro Y; Kubota T; Irahara M; Ogata T; Fukami M
    J Steroid Biochem Mol Biol; 2016 Apr; 158():31-37. PubMed ID: 26877255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
    O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
    J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.